01.06.1999 | ORIGINAL ARTICLE
Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes
Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 2/1999
Einloggen, um Zugang zu erhalten